Psi represses EGFR signalling in the neural stem cell niche to inhibit neuroblast proliferation in the Drosophila brain

This study reveals that in the *Drosophila* brain, the glioma-associated protein Psi, expressed in cortex glia, inhibits neural stem cell overproliferation by transcriptionally repressing EGFR ligands, thereby highlighting the critical role of niche-mediated communication in regulating stem cell fate and preventing tumorigenesis.

The Gist

Imagine the developing brain as a bustling construction site. In this site, there are two main groups of workers: the Neural Stem Cells (NSCs), who are the master builders capable of creating new rooms (neurons) and walls (glia), and the Cortex Glia, who act as the site managers and foremen.

The site managers (Cortex Glia) have a very important job: they surround the master builders, provide them with tools, and, crucially, tell them when to stop building and when to start working. If the managers lose control, the master builders might go crazy, building too many rooms and causing a chaotic, dangerous structure. In humans, this chaos is similar to a type of brain cancer called oligodendroglioma.

This paper investigates a specific "site manager" protein called Psi (which is the fly version of a human protein called FUBP1). The researchers wanted to know: What happens if this manager gets fired (knocked out) in the brain?

The Plot Twist: A Manager with Two Faces

Usually, when you fire a manager, you expect the team to slow down. But here, the story is a bit more complex. The researchers found that Psi has a "split personality" depending on who it is talking to:

1. Inside the Management Office (The Glia): Psi is a motivator. It tells the Cortex Glia cells to grow and multiply. When they fired Psi, the management team shrank. The site managers couldn't keep up with the workload.
2. Outside the Office (The Neighbors): Psi is a traffic cop. It stops the master builders (NSCs) from going wild. When they fired Psi, the traffic cop disappeared, and the master builders started multiplying uncontrollably, creating a tumor-like mass.

The Secret Weapon: The "Stop" and "Go" Signals

How does Psi control the master builders? It uses a communication system called EGFR signaling, which is like a walkie-talkie network. Psi controls two specific messages sent over this walkie-talkie:

• Message A (Spi): This is a "Go" signal for the managers themselves. When Psi is gone, the managers stop sending this signal to each other, so they stop growing.
• Message B (Grk): This is a "Go" signal for the master builders. Normally, Psi silences this message so the builders don't get too excited. But when Psi is fired, the "Grk" message starts blasting loudly. The master builders hear this loud "Go!" signal and start dividing non-stop.

The Analogy:
Think of the Cortex Glia as a factory that makes two types of products.

• Product 1 (Spi) is a self-care kit for the factory workers. Without Psi, the factory stops making these kits, so the workers get tired and leave (fewer glia).
• Product 2 (Grk) is a loud siren that tells the neighboring construction crew to build faster. Normally, Psi keeps the siren off. When Psi is gone, the siren blares 24/7. The construction crew (NSCs) hears the siren and goes into overdrive, building a chaotic, dangerous skyscraper (the tumor).

Why This Matters for Humans

The human version of Psi is called FUBP1. In many brain cancers, the gene for FUBP1 is broken or missing.

This study suggests that when FUBP1 breaks in humans, it doesn't just stop the cancer cells from growing; it accidentally turns up the volume on the "grow" signals (like Grk) that the cancer cells send to their neighbors. This causes the stem cells in the brain to multiply uncontrollably, driving the cancer forward.

The Takeaway

This research is like finding the missing piece of a puzzle. It shows that brain tumors aren't just about the cancer cells being "bad." They are often caused by a breakdown in the conversation between the support cells (glia) and the stem cells.

By understanding that a broken "traffic cop" (Psi/FUBP1) leads to a blaring "Go" siren (EGFR/Grk), scientists might be able to design new drugs to turn that siren down, even if the manager is already gone. It's a reminder that in the brain, as in a city, keeping the communication lines clear is just as important as having good workers.

Technical Summary

1. Problem Statement

Neural stem cells (NSCs) rely on a delicate balance between self-renewal and differentiation, regulated by both intrinsic genetic programs and extrinsic cues from the surrounding microenvironment (the stem cell niche). Dysregulation of this communication is a known driver of brain cancers, particularly gliomas.

• The Specific Gap: The FUBP1 gene is frequently mutated in oligodendroglioma (a type of low-grade glioma). While FUBP1 is often characterized as an oncogene (activating MYC), its role as a tumor suppressor in oligodendroglioma is poorly understood. The molecular mechanisms by which FUBP1 loss-of-function leads to glioma initiation, specifically regarding NSC-niche communication, remain undefined.
• The Model: The study utilizes Drosophila melanogaster, where the single orthologue of FUBP1 is Psi (P-element somatic inhibitor). The larval brain NSC niche is comprised of cortex glia, which encase NSCs and provide structural and signaling support.

2. Methodology

The authors employed a multi-omics and genetic approach to dissect the cell-autonomous and non-autonomous functions of Psi in the cortex glia.

• Genetic Manipulation:
  • Used GMR54H02-GAL4 (wrapper-GAL4) to drive tissue-specific knockdown (KD) of Psi specifically in cortex glia.
  • Utilized RNAi lines for Psi, spitz (spi), and gurken (grk) to perform single and double KD experiments.
  • Employed temperature-sensitive GAL80 systems for temporal control where necessary.
• Phenotypic Analysis:
  • Immunofluorescence & Microscopy: Confocal microscopy (Zeiss LSM800) with 3D reconstruction (Imaris) to quantify cortex glia numbers, NSC numbers (using deadpan-GFP), and mitotic NSCs (using anti-pH3).
  • qPCR: Validated knockdown efficiency at the mRNA level.
• Transcriptomics & Epigenomics:
  • FACS Sorting: Isolated cortex glia (mCherry+) and NSCs (dpn-GFP+) from larval brains.
  • RNA-seq: Performed bulk RNA sequencing on FACS-sorted cells to identify differentially expressed (DE) genes in both the niche (glia) and the stem cells (NSCs) upon Psi KD.
  • Targeted DamID (TaDa): Mapped genome-wide DNA binding sites of Psi in cortex glia using a Dam-Psi fusion protein to identify direct transcriptional targets.
  • Splicing Analysis: Used rMATS to identify differential splicing events.
• Bioinformatics:
  • DESeq2 for differential expression analysis.
  • Gene Ontology (GO) and KEGG pathway enrichment analysis.
  • Intersection of TaDa binding data with RNA-seq DE data to distinguish direct vs. indirect targets.

3. Key Contributions

1. Dual Role of FUBP1/Psi: The study establishes that Psi (and by extension FUBP1) has a dual, context-dependent function: it acts as a pro-proliferative factor cell-autonomously within the cortex glia, but as a tumor suppressor cell-non-autonomously by repressing NSC overproliferation.
2. Mechanism of NSC Control: It identifies EGFR signaling as the critical pathway mediating the niche-to-stem cell communication. Specifically, Psi directly represses the transcription of EGFR ligands.
3. Ligand Specificity: The study distinguishes the distinct roles of two EGFR ligands, spitz (spi) and gurken (grk), in the same niche:
   • spi acts autocrinely to promote glial growth.
   • grk acts paracrinely to drive NSC expansion.
4. Direct Transcriptional Repression: Through TaDa and RNA-seq integration, the authors demonstrate that Psi functions primarily as a transcriptional repressor in the glial niche, directly binding to and repressing spi and grk.

4. Key Results

• Phenotypic Effects of Psi KD in Cortex Glia:
  • Glial Defect: Psi KD significantly reduced the number of cortex glia cells, indicating Psi is required cell-autonomously for glial proliferation.
  • NSC Expansion: Paradoxically, Psi KD in the niche led to a significant increase in the number of neighboring NSCs and a higher proportion of NSCs in mitosis.
• Transcriptomic Profiling:
  • In Glia: Psi KD upregulated genes involved in cell migration, actin organization, and signal transduction. Crucially, EGFR ligands spi and grk were upregulated.
  • In NSCs: NSCs associated with the Psi-KD niche showed upregulation of EGFR/MAPK pathway components (e.g., S6kII, Pi3K68D, phyl) and downregulation of negative regulators (e.g., Spred), confirming hyperactivation of EGFR signaling.
• Direct Target Validation (TaDa + RNA-seq):
  • Intersection analysis revealed that Psi binds directly to the genomic loci of spi and grk.
  • 78% of direct targets were upregulated upon Psi KD, confirming Psi acts as a repressor.
  • Most transcriptional changes occurred independently of splicing, highlighting the transcriptional regulatory role of Psi in this context.
• Genetic Rescue/Epistasis:
  • Spi KD: Reducing spi in glia reduced glial numbers (enhancing the Psi KD phenotype) but did not rescue the NSC overproliferation. This confirms spi drives glial growth (autocrine) but is not the driver of NSC expansion.
  • Grk KD: Reducing grk in glia did not affect glial numbers alone but completely suppressed the NSC overproliferation caused by Psi KD.
  • Conclusion: The NSC expansion is driven specifically by the de-repression of grk (paracrine signaling), while glial proliferation is driven by spi (autocrine signaling).

5. Significance and Implications

• Mechanism of Glioma Initiation: The findings provide a mechanistic model for how FUBP1 loss-of-function drives oligodendroglioma. Loss of FUBP1 in glial-like cells leads to the de-repression of EGFR ligands (specifically GRK in mammals), which hyperactivates EGFR signaling in neighboring stem/progenitor cells, driving uncontrolled proliferation and tumor growth.
• Niche-Stem Cell Communication: The study highlights the complexity of the stem cell niche, showing that a single factor (Psi/FUBP1) can simultaneously regulate the growth of the niche cells and the fate of the stem cells via distinct ligands (spi vs. grk).
• Therapeutic Insight: Understanding that FUBP1 loss drives glioma via EGFR dysregulation suggests that targeting EGFR signaling or the specific ligands involved could be a therapeutic strategy for FUBP1-mutant gliomas.
• Conservation: Given the high conservation between Psi and FUBP1, these findings in Drosophila offer a robust framework for understanding human brain cancer biology, specifically the transition from normal development to tumorigenesis driven by niche signaling defects.